NanoMedSyn
www.nanomedsyn.comNanoMedSyn develops new targeted therapeutics to treat Lysosomal Storage Disorders. Thanks to proprietary synthetic derivatives (named AMFA), NanoMedSyn provides a compound with an high affinity for the mannose 6-phosphate receptor, responsible for the targeting of enzymes to the lysosome. A new generation of enzymes for the therapy of Lysosomal Diseases is now possible.
Read more
NanoMedSyn develops new targeted therapeutics to treat Lysosomal Storage Disorders. Thanks to proprietary synthetic derivatives (named AMFA), NanoMedSyn provides a compound with an high affinity for the mannose 6-phosphate receptor, responsible for the targeting of enzymes to the lysosome. A new generation of enzymes for the therapy of Lysosomal Diseases is now possible.
Read more
Country
City (Headquarters)
Montpellier
Industry
Employees
1-10
Founded
2012
Social
Employees statistics
View all employeesPotential Decision Makers
Research Manager
Email ****** @****.comPhone (***) ****-****Project Manager
Email ****** @****.comPhone (***) ****-****
Technologies
(7)
